2:05 PM
Jul 18, 2017
 |  BC Innovations  |  Distillery Therapeutics


INDICATION: Breast cancer; melanoma

Cell culture and mouse studies suggest inhibiting the long non-coding RNA (lncRNA) ORILNC1 could help treat KRAS-driven breast cancer and

Read the full 107 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >